Avopef

Etoposide · AVYXA Pharma, LLC
CANCER MEDICINE · PRESCRIPTION ONLY (USA)

Avopef ingredients

Active ingredientStrength
Etoposide500 mg/25mL, 100 mg/5mL

What Avopef is used for

Avopef is a cancer medicine (topoisomerase inhibitor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Avopef
Generic name
Etoposide
Made by
AVYXA Pharma, LLC
Forms
Injection
Given
Intravenous
Drug class
Topoisomerase Inhibitor
FDA approval
New drug application (NDA) NDA220200
On the US market since
2026

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Avopef?

Avopef (Etoposide) is a cancer medicine made by AVYXA Pharma, LLC, approved by the US FDA.

What are the ingredients of Avopef?

Avopef contains Etoposide (500 mg/25mL, 100 mg/5mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.